In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Trading Standards at Hull City Council tested the pills and found they did not support weight loss because they did not ...
Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the ...
Glucomannan: A soluble fiber derived from the root of the konjac plant, Glucomannan expands in the stomach, promoting a ...
Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...
Many companies, including market leaders Novo Nordisk (DK:NOVO.B) (NVO) and Eli Lilly & Co. (LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty ...